Bridgeway Capital Management’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.1K | Hold |
19,400
| – | – | ﹤0.01% | 1140 |
|
|
2025
Q1 | $29.1K | Sell |
19,400
-2,000
| -9% | -$3K | ﹤0.01% | 1145 |
|
|
2024
Q4 | $108K | Sell |
21,400
-700
| -3% | -$3.52K | ﹤0.01% | 1102 |
|
|
2024
Q3 | $178K | Hold |
22,100
| – | – | ﹤0.01% | 1090 |
|
|
2024
Q2 | $127K | Sell |
22,100
-11,500
| -34% | -$66.2K | ﹤0.01% | 1138 |
|
|
2024
Q1 | $400K | Buy |
33,600
+10,000
| +42% | +$119K | 0.01% | 981 |
|
|
2023
Q4 | $441K | Hold |
23,600
| – | – | 0.01% | 971 |
|
|
2023
Q3 | $224K | Hold |
23,600
| – | – | 0.01% | 1077 |
|
|
2023
Q2 | $337K | Hold |
23,600
| – | – | 0.01% | 1017 |
|
|
2023
Q1 | $364K | Hold |
23,600
| – | – | 0.01% | 959 |
|
|
2022
Q4 | $317K | Hold |
23,600
| – | – | 0.01% | 976 |
|
|
2022
Q3 | $323K | Hold |
23,600
| – | – | 0.01% | 1016 |
|
|
2022
Q2 | $268K | Hold |
23,600
| – | – | 0.01% | 1024 |
|
|
2022
Q1 | $315K | Hold |
23,600
| – | – | 0.01% | 1063 |
|
|
2021
Q4 | $415K | Hold |
23,600
| – | – | 0.01% | 1030 |
|
|
2021
Q3 | $749K | Hold |
23,600
| – | – | 0.01% | 914 |
|
|
2021
Q2 | $2.02M | Buy |
23,600
+1,100
| +5% | +$94.2K | 0.04% | 631 |
|
|
2021
Q1 | $628K | Buy |
+22,500
| New | +$628K | 0.01% | 1033 |
|